25 May 2013
Keywords: Mylan, Antivirals, ARVs, India, NACO, Supply agreement
Article | 04 September 2012
Leading USA-based generic drugmaker Mylan (Nasdaq: MYL) says that its India-based subsidiary Mylan Laboratories Limited has been selected as a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 September 2012
5 September 2012
24 May 2013
© 2013 thepharmaletter.com